MF
AGIO icon

Magnetar Financial’s Agios Pharmaceuticals AGIO Stock Holding History

Magnetar Financial’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5,936
Closed -$201K – 1145
2026
Q1 		$201K Buy
+5,936
New +$168K ﹤0.01% 897
2025
Q1 		– Sell
-6,501
Closed -$214K – 724
2024
Q4 		$214K Buy
+6,501
New +$305K ﹤0.01% 542
2021
Q3 		– Sell
-7,652
Closed -$422K – 1296
2021
Q2 		$422K Buy
+7,652
New +$428K ﹤0.01% 935
2021
Q1 		– Sell
-5,123
Closed -$222K – 1032
2020
Q4 		$222K Sell
5,123
-7,549
-60% -$298K ﹤0.01% 664
2020
Q3 		$444K Buy
+12,672
New +$555K 0.01% 467
2020
Q2 		– Sell
-7,927
Closed -$281K – 428
2020
Q1 		$281K Buy
+7,927
New +$366K 0.01% 351

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Magnetar Financial's AGIO Position: Q2 2026 in Review

Magnetar Financial sold out of Agios Pharmaceuticals (AGIO) in Q2 2026, closing a stake of 5,936 shares — an estimated $201K sold.

Magnetar Financial first reported a position in AGIO in Q1 2020 and held it in 6 quarters. The position peaked at $444K in Q3 2020. 239 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Magnetar Financial reported no remaining Agios Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Magnetar Financial sold 5,936 Agios Pharmaceuticals shares in Q2 2026, an estimated $201K.
  • Magnetar Financial first reported a position in Agios Pharmaceuticals in Q1 2020 and held it in 6 quarters.
  • Magnetar Financial's Agios Pharmaceuticals position peaked at $444K in Q3 2020.
  • 239 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Magnetar Financial's 13F filing for Q2 2026, filed 14 Aug 2026.